High Dose Ribavirin and Peginterferon for Chronic Hepatitis C Non-responders or Relapsers

被引：0
|
作者：
Gara, Naveen [1 ]
Abdalla, Adil A. [1 ]
Rivera, Elenita M. [1 ]
Zhao, Xiongce [1 ]
Fryzek, Nancy [1 ]
Noureddin, Mazen [1 ]
Sarkar, Souvik [1 ]
Heller, Theo [1 ]
Rotman, Yaron [1 ]
Doo, Edward [1 ]
Liang, T. Jake [1 ]
Hoofnagle, Jay H. [1 ]
Ghany, Marc G. [1 ]
机构：
[1] NIDDK, NIH, Bethesda, MD USA
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1836
引用
收藏
页码：1049A / 1049A
页数：1
相关论文
共 50 条
  • [41] THALIDOMIDE WITH PEGINTERFERON ALFA-2B AND RIBAVIRIN IN THE TREATMENT OF NON-RESPONDERS GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS (TRITAL): PROOF OF CONCEPT
    Pardo, Benjamin
    Garcia-Collado, Carlos
    Grande, Lourdes
    Paradas, Car-men
    Rodriguez-Lopez, Olga
    Morillo, Ramon
    Hoyas, Elena
    Artacho Criado, Silvia
    Dorantes, Benito
    Romero-Gomez, Manuel
    HEPATOLOGY, 2009, 50 (04) : 722A - 722A
  • [42] High Sustained Virologic Response (SVR) Among Genotype I Previous Non-Responders and Relapsers to Peginterferon/Ribavirin When Re-Treated with Boceprevir (BOC) Plus Peginterferon Alfa-2A/Ribavirin
    Flamm, Steven L.
    Lawitz, Eric J.
    Jacobson, Ira M.
    Rubin, Raymond A.
    Bourliere, Marc
    Hezode, C.
    Vierling, J.
    Niederau, Claus
    Sherman, Morris
    Goteti, Venkata S.
    Vilchez, Regis A.
    Brass, Clifford A.
    Albrecht, Janice K.
    Poordad, Fred
    GASTROENTEROLOGY, 2011, 140 (05) : S145 - S145
  • [43] HIGH SUSTAINED VIROLOGIC RESPONSE (SVR) AMONG GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2A/RIBAVIRIN
    Flamm, S.
    Lawitz, E.
    Jacobson, I.
    Rubin, R.
    Bourliere, M.
    Hezode, C.
    Vierling, J.
    Niederau, C.
    Sherman, M.
    Goteti, V.
    Vilchez, R.
    Brass, C.
    Albrecht, J.
    Poordad, F.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S541 - S542
  • [44] High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C
    Lindahl, K
    Stahle, L
    Bruchfeld, A
    Schvarcz, R
    HEPATOLOGY, 2005, 41 (02) : 275 - 279
  • [45] Double-dose peginterferon alfa-2B with weight-based ribavirin improves response for interferon/ribavirin non-responders with hepatitis C: Final results of "RENEW"
    Gross, J
    Johnson, S
    Kwo, P
    Afdhal, N
    Flamm, S
    Therneau, T
    HEPATOLOGY, 2005, 42 (04) : 219A - 220A
  • [46] Combination therapy with interferon alfa-2b, ribavirin, and amantadine in chronic hepatitis C non-responders to interferon and ribavirin
    Pande, H
    Thuluvath, PJ
    Jaffer, SA
    Maygers, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S96 - S96
  • [47] High and daily dosing therapy with consensus interferon plus ribavirin for combination therapy non-responders with chronic hepatitis C.
    Kaiser, S
    Kreysel, C
    Hass, H
    Gregor, M
    HEPATOLOGY, 2001, 34 (04) : 582A - 582A
  • [48] Predictive factors of a beneficial response to combination therapy of chronic hepatitis C in non-responders or relapsers to previous interferon treatment.
    Akarca, US
    Sayiner, A
    Ersoz, G
    Gunsar, F
    Ozacar, T
    Batur, Y
    HEPATOLOGY, 1999, 30 (04) : 631A - 631A
  • [49] High response rates with peginterferon alfa-2a (40KD) (Pegasys®) plus ribavirin (Copegus®) in Japanese non-responders or relapsers to conventional interferon
    Izumi, Namiki
    Iino, Shiro
    Okuno, Tadao
    Omata, Massao
    Kiyosawa, Kendo
    Kumada, Hiromitsu
    Hayashi, Norio
    Yamada, Gotaro
    Sakai, Takahiro
    GASTROENTEROLOGY, 2006, 130 (04) : A841 - A842
  • [50] Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis
    Camma, Calogero
    Cabibbo, Giuseppe
    Bronte, Fabrizio
    Enea, Marco
    Licata, Anna
    Attanasio, Massimo
    Andriulli, Angelo
    Craxi, Antonio
    JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 675 - 681
12345